Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
AIM 13 August 2024 NOTICE 13/08/2024 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM At the request of the company the following securities have been cancelled from...
Destiny Pharma PLC 12 August 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Last Day of Dealings on AIM Brighton, United Kingdom - 12 August 2024 - Destiny Pharma plc (AIM:...
Destiny Pharma PLC 05 August 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Director/PDMR Shareholding Brighton, United Kingdom - 5 August 2024 - Destiny Pharma plc (AIM:...
Destiny Pharma PLC on Monday announced positive data for its lead drug exeporfinium chloride, known as XF-73, and to ...
Destiny Pharma PLC 31 July 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Result of General Meeting and Cancellation of Admission to Trading on AIM Brighton, United...
Destiny Pharma PLC on Monday proposed going private to pursue funding opportunities after failing to secure a licensi ...
Destiny Pharma PLC 15 July 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED...
Destiny Pharma PLC 20 June 2024 20 June 2024 Destiny Pharma plc ("Destiny Pharma" or the "Company") Exercise of Options and Total Voting Rights Brighton, United Kingdom - 20 June 2024 ...
C - biotechnology company, focused on developing and commercialising medicines for life-threatening infections - Annou ...
Destiny Pharma PLC 18 June 2024 Destiny Pharma plc ("Destiny Pharma" or "the Company") Efficacy of XF-70 Demonstrated: A Potential New Agent for the Treatment of Fungal Skin Infections ...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 3 | 3 | 3 | 0 | 0 | DE |
| 4 | 0 | 0 | 3 | 3 | 3 | 0 | 0 | DE |
| 12 | 0 | 0 | 3 | 3 | 3 | 0 | 0 | DE |
| 26 | -2 | -40 | 5 | 7.75 | 2.25 | 294955 | 3.34713705 | DE |
| 52 | -71.5 | -95.9731543624 | 74.5 | 74.5 | 2.25 | 433363 | 14.90538286 | DE |
| 156 | -96 | -96.9696969697 | 99 | 101 | 2.25 | 300876 | 31.16011639 | DE |
| 260 | -41 | -93.1818181818 | 44 | 246 | 2.25 | 206326 | 39.11735348 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
